nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroflumethiazide—KCNMA1—epilepsy syndrome	0.181	0.552	CbGaD
Hydroflumethiazide—CA4—epilepsy syndrome	0.147	0.448	CbGaD
Hydroflumethiazide—CA14—Lacosamide—epilepsy syndrome	0.0328	0.0687	CbGbCtD
Hydroflumethiazide—CA5B—Lacosamide—epilepsy syndrome	0.0272	0.0568	CbGbCtD
Hydroflumethiazide—CA9—Lacosamide—epilepsy syndrome	0.0233	0.0488	CbGbCtD
Hydroflumethiazide—CA14—Acetazolamide—epilepsy syndrome	0.0226	0.0473	CbGbCtD
Hydroflumethiazide—CA1—Lacosamide—epilepsy syndrome	0.0218	0.0456	CbGbCtD
Hydroflumethiazide—CA14—Zonisamide—epilepsy syndrome	0.0209	0.0437	CbGbCtD
Hydroflumethiazide—CA4—Lacosamide—epilepsy syndrome	0.0205	0.0429	CbGbCtD
Hydroflumethiazide—CA2—Lacosamide—epilepsy syndrome	0.0189	0.0394	CbGbCtD
Hydroflumethiazide—CA5B—Acetazolamide—epilepsy syndrome	0.0187	0.0391	CbGbCtD
Hydroflumethiazide—CA7—Acetazolamide—epilepsy syndrome	0.0187	0.0391	CbGbCtD
Hydroflumethiazide—CA5B—Zonisamide—epilepsy syndrome	0.0173	0.0362	CbGbCtD
Hydroflumethiazide—CA7—Zonisamide—epilepsy syndrome	0.0173	0.0362	CbGbCtD
Hydroflumethiazide—CA12—Acetazolamide—epilepsy syndrome	0.016	0.0336	CbGbCtD
Hydroflumethiazide—CA9—Acetazolamide—epilepsy syndrome	0.016	0.0336	CbGbCtD
Hydroflumethiazide—CA1—Acetazolamide—epilepsy syndrome	0.015	0.0314	CbGbCtD
Hydroflumethiazide—CA9—Zonisamide—epilepsy syndrome	0.0148	0.0311	CbGbCtD
Hydroflumethiazide—CA12—Zonisamide—epilepsy syndrome	0.0148	0.0311	CbGbCtD
Hydroflumethiazide—CA4—Acetazolamide—epilepsy syndrome	0.0141	0.0295	CbGbCtD
Hydroflumethiazide—CA1—Zonisamide—epilepsy syndrome	0.0139	0.0291	CbGbCtD
Hydroflumethiazide—CA4—Zonisamide—epilepsy syndrome	0.0131	0.0273	CbGbCtD
Hydroflumethiazide—CA2—Acetazolamide—epilepsy syndrome	0.013	0.0271	CbGbCtD
Hydroflumethiazide—CA5B—Topiramate—epilepsy syndrome	0.0126	0.0264	CbGbCtD
Hydroflumethiazide—CA7—Topiramate—epilepsy syndrome	0.0126	0.0264	CbGbCtD
Hydroflumethiazide—CA2—Zonisamide—epilepsy syndrome	0.012	0.0251	CbGbCtD
Hydroflumethiazide—CA9—Topiramate—epilepsy syndrome	0.0108	0.0226	CbGbCtD
Hydroflumethiazide—CA12—Topiramate—epilepsy syndrome	0.0108	0.0226	CbGbCtD
Hydroflumethiazide—CA1—Topiramate—epilepsy syndrome	0.0101	0.0212	CbGbCtD
Hydroflumethiazide—CA4—Topiramate—epilepsy syndrome	0.00952	0.0199	CbGbCtD
Hydroflumethiazide—CA2—Topiramate—epilepsy syndrome	0.00875	0.0183	CbGbCtD
Hydroflumethiazide—SLC12A1—ganglion—epilepsy syndrome	0.0015	0.0501	CbGeAlD
Hydroflumethiazide—KCNMA1—ganglion—epilepsy syndrome	0.00136	0.0454	CbGeAlD
Hydroflumethiazide—KCNMA1—hindbrain—epilepsy syndrome	0.00103	0.0344	CbGeAlD
Hydroflumethiazide—CA4—ganglion—epilepsy syndrome	0.000809	0.0269	CbGeAlD
Hydroflumethiazide—ATP1A1—hindbrain—epilepsy syndrome	0.000664	0.0221	CbGeAlD
Hydroflumethiazide—CA14—telencephalon—epilepsy syndrome	0.000646	0.0215	CbGeAlD
Hydroflumethiazide—SLC12A1—forebrain—epilepsy syndrome	0.000631	0.021	CbGeAlD
Hydroflumethiazide—CA4—hindbrain—epilepsy syndrome	0.000613	0.0204	CbGeAlD
Hydroflumethiazide—KCNMA1—brainstem—epilepsy syndrome	0.000592	0.0197	CbGeAlD
Hydroflumethiazide—SLC12A1—telencephalon—epilepsy syndrome	0.00058	0.0193	CbGeAlD
Hydroflumethiazide—KCNMA1—forebrain—epilepsy syndrome	0.000572	0.019	CbGeAlD
Hydroflumethiazide—CA7—midbrain—epilepsy syndrome	0.000557	0.0186	CbGeAlD
Hydroflumethiazide—CA12—forebrain—epilepsy syndrome	0.000548	0.0183	CbGeAlD
Hydroflumethiazide—KCNMA1—telencephalon—epilepsy syndrome	0.000526	0.0175	CbGeAlD
Hydroflumethiazide—Bendroflumethiazide—KCNMA1—epilepsy syndrome	0.000511	0.177	CrCbGaD
Hydroflumethiazide—CA2—hindbrain—epilepsy syndrome	0.000509	0.0169	CbGeAlD
Hydroflumethiazide—CA14—medulla oblongata—epilepsy syndrome	0.000508	0.0169	CbGeAlD
Hydroflumethiazide—CA12—telencephalon—epilepsy syndrome	0.000504	0.0168	CbGeAlD
Hydroflumethiazide—CA14—midbrain—epilepsy syndrome	0.000464	0.0155	CbGeAlD
Hydroflumethiazide—CA14—spinal cord—epilepsy syndrome	0.000453	0.0151	CbGeAlD
Hydroflumethiazide—CA1—forebrain—epilepsy syndrome	0.000434	0.0145	CbGeAlD
Hydroflumethiazide—CA7—cerebellum—epilepsy syndrome	0.000431	0.0144	CbGeAlD
Hydroflumethiazide—Bendroflumethiazide—CA4—epilepsy syndrome	0.000414	0.144	CrCbGaD
Hydroflumethiazide—SLC12A1—spinal cord—epilepsy syndrome	0.000406	0.0135	CbGeAlD
Hydroflumethiazide—CA1—telencephalon—epilepsy syndrome	0.000399	0.0133	CbGeAlD
Hydroflumethiazide—ATP1A1—brainstem—epilepsy syndrome	0.00038	0.0127	CbGeAlD
Hydroflumethiazide—CA9—cerebellum—epilepsy syndrome	0.000378	0.0126	CbGeAlD
Hydroflumethiazide—KCNMA1—midbrain—epilepsy syndrome	0.000377	0.0126	CbGeAlD
Hydroflumethiazide—ATP1A1—forebrain—epilepsy syndrome	0.000367	0.0122	CbGeAlD
Hydroflumethiazide—Methyclothiazide—CA4—epilepsy syndrome	0.000363	0.126	CrCbGaD
Hydroflumethiazide—SLC12A1—head—epilepsy syndrome	0.000361	0.012	CbGeAlD
Hydroflumethiazide—CA14—cerebellum—epilepsy syndrome	0.000359	0.012	CbGeAlD
Hydroflumethiazide—Hydrochlorothiazide—KCNMA1—epilepsy syndrome	0.000354	0.123	CrCbGaD
Hydroflumethiazide—Cyclothiazide—CA4—epilepsy syndrome	0.000352	0.122	CrCbGaD
Hydroflumethiazide—CA4—brainstem—epilepsy syndrome	0.000352	0.0117	CbGeAlD
Hydroflumethiazide—CA7—brain—epilepsy syndrome	0.00035	0.0117	CbGeAlD
Hydroflumethiazide—Chlorothiazide—CA4—epilepsy syndrome	0.00035	0.121	CrCbGaD
Hydroflumethiazide—SLC12A1—nervous system—epilepsy syndrome	0.000342	0.0114	CbGeAlD
Hydroflumethiazide—CA4—forebrain—epilepsy syndrome	0.000339	0.0113	CbGeAlD
Hydroflumethiazide—ATP1A1—telencephalon—epilepsy syndrome	0.000338	0.0112	CbGeAlD
Hydroflumethiazide—SLC12A1—central nervous system—epilepsy syndrome	0.00033	0.011	CbGeAlD
Hydroflumethiazide—KCNMA1—head—epilepsy syndrome	0.000327	0.0109	CbGeAlD
Hydroflumethiazide—CA12—head—epilepsy syndrome	0.000314	0.0105	CbGeAlD
Hydroflumethiazide—CA4—telencephalon—epilepsy syndrome	0.000312	0.0104	CbGeAlD
Hydroflumethiazide—KCNMA1—nervous system—epilepsy syndrome	0.00031	0.0103	CbGeAlD
Hydroflumethiazide—KCNMA1—central nervous system—epilepsy syndrome	0.000299	0.00995	CbGeAlD
Hydroflumethiazide—CA12—nervous system—epilepsy syndrome	0.000298	0.00991	CbGeAlD
Hydroflumethiazide—KCNMA1—cerebellum—epilepsy syndrome	0.000292	0.00973	CbGeAlD
Hydroflumethiazide—CA14—brain—epilepsy syndrome	0.000292	0.00971	CbGeAlD
Hydroflumethiazide—CA2—brainstem—epilepsy syndrome	0.000292	0.00971	CbGeAlD
Hydroflumethiazide—Hydrochlorothiazide—CA4—epilepsy syndrome	0.000287	0.0995	CrCbGaD
Hydroflumethiazide—CA12—central nervous system—epilepsy syndrome	0.000286	0.00954	CbGeAlD
Hydroflumethiazide—CA5B—head—epilepsy syndrome	0.000281	0.00938	CbGeAlD
Hydroflumethiazide—CA2—forebrain—epilepsy syndrome	0.000281	0.00937	CbGeAlD
Hydroflumethiazide—CA1—spinal cord—epilepsy syndrome	0.00028	0.00932	CbGeAlD
Hydroflumethiazide—CA5B—nervous system—epilepsy syndrome	0.000267	0.00889	CbGeAlD
Hydroflumethiazide—ATP1A1—medulla oblongata—epilepsy syndrome	0.000265	0.00884	CbGeAlD
Hydroflumethiazide—SLC12A1—brain—epilepsy syndrome	0.000262	0.00872	CbGeAlD
Hydroflumethiazide—CA2—telencephalon—epilepsy syndrome	0.000259	0.00862	CbGeAlD
Hydroflumethiazide—CA5B—central nervous system—epilepsy syndrome	0.000257	0.00856	CbGeAlD
Hydroflumethiazide—Trichlormethiazide—CA4—epilepsy syndrome	0.000256	0.0887	CrCbGaD
Hydroflumethiazide—CA1—head—epilepsy syndrome	0.000249	0.00828	CbGeAlD
Hydroflumethiazide—CA4—medulla oblongata—epilepsy syndrome	0.000245	0.00817	CbGeAlD
Hydroflumethiazide—ATP1A1—midbrain—epilepsy syndrome	0.000242	0.00808	CbGeAlD
Hydroflumethiazide—KCNMA1—brain—epilepsy syndrome	0.000237	0.0079	CbGeAlD
Hydroflumethiazide—ATP1A1—spinal cord—epilepsy syndrome	0.000237	0.00788	CbGeAlD
Hydroflumethiazide—CA1—nervous system—epilepsy syndrome	0.000236	0.00785	CbGeAlD
Hydroflumethiazide—CA12—brain—epilepsy syndrome	0.000227	0.00757	CbGeAlD
Hydroflumethiazide—CA1—central nervous system—epilepsy syndrome	0.000227	0.00756	CbGeAlD
Hydroflumethiazide—CA4—midbrain—epilepsy syndrome	0.000224	0.00746	CbGeAlD
Hydroflumethiazide—CA4—spinal cord—epilepsy syndrome	0.000219	0.00728	CbGeAlD
Hydroflumethiazide—ATP1A1—head—epilepsy syndrome	0.00021	0.007	CbGeAlD
Hydroflumethiazide—CA5B—brain—epilepsy syndrome	0.000204	0.00679	CbGeAlD
Hydroflumethiazide—CA2—medulla oblongata—epilepsy syndrome	0.000203	0.00677	CbGeAlD
Hydroflumethiazide—ATP1A1—nervous system—epilepsy syndrome	0.000199	0.00664	CbGeAlD
Hydroflumethiazide—CA4—head—epilepsy syndrome	0.000194	0.00647	CbGeAlD
Hydroflumethiazide—ATP1A1—central nervous system—epilepsy syndrome	0.000192	0.00639	CbGeAlD
Hydroflumethiazide—ATP1A1—cerebellum—epilepsy syndrome	0.000188	0.00625	CbGeAlD
Hydroflumethiazide—CA2—midbrain—epilepsy syndrome	0.000186	0.00619	CbGeAlD
Hydroflumethiazide—CA4—nervous system—epilepsy syndrome	0.000184	0.00614	CbGeAlD
Hydroflumethiazide—CA2—spinal cord—epilepsy syndrome	0.000181	0.00604	CbGeAlD
Hydroflumethiazide—CA1—brain—epilepsy syndrome	0.00018	0.006	CbGeAlD
Hydroflumethiazide—CA4—central nervous system—epilepsy syndrome	0.000177	0.00591	CbGeAlD
Hydroflumethiazide—CA4—cerebellum—epilepsy syndrome	0.000173	0.00577	CbGeAlD
Hydroflumethiazide—CA2—head—epilepsy syndrome	0.000161	0.00537	CbGeAlD
Hydroflumethiazide—CA2—nervous system—epilepsy syndrome	0.000153	0.00509	CbGeAlD
Hydroflumethiazide—ATP1A1—brain—epilepsy syndrome	0.000152	0.00507	CbGeAlD
Hydroflumethiazide—CA2—central nervous system—epilepsy syndrome	0.000147	0.0049	CbGeAlD
Hydroflumethiazide—CA2—cerebellum—epilepsy syndrome	0.000144	0.00479	CbGeAlD
Hydroflumethiazide—CA4—brain—epilepsy syndrome	0.000141	0.00469	CbGeAlD
Hydroflumethiazide—Constipation—Fosphenytoin—epilepsy syndrome	0.000138	0.00167	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Phenytoin—epilepsy syndrome	0.000137	0.00167	CcSEcCtD
Hydroflumethiazide—Urticaria—Propofol—epilepsy syndrome	0.000137	0.00167	CcSEcCtD
Hydroflumethiazide—Photosensitivity reaction—Gabapentin—epilepsy syndrome	0.000137	0.00166	CcSEcCtD
Hydroflumethiazide—Vomiting—Lacosamide—epilepsy syndrome	0.000137	0.00166	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Oxcarbazepine—epilepsy syndrome	0.000136	0.00166	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Vigabatrin—epilepsy syndrome	0.000136	0.00166	CcSEcCtD
Hydroflumethiazide—Nausea—Rufinamide—epilepsy syndrome	0.000136	0.00165	CcSEcCtD
Hydroflumethiazide—Rash—Lacosamide—epilepsy syndrome	0.000135	0.00165	CcSEcCtD
Hydroflumethiazide—Dermatitis—Lacosamide—epilepsy syndrome	0.000135	0.00164	CcSEcCtD
Hydroflumethiazide—Hyperglycaemia—Gabapentin—epilepsy syndrome	0.000135	0.00164	CcSEcCtD
Hydroflumethiazide—Headache—Lacosamide—epilepsy syndrome	0.000135	0.00163	CcSEcCtD
Hydroflumethiazide—Anorexia—Clonazepam—epilepsy syndrome	0.000134	0.00163	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Diazepam—epilepsy syndrome	0.000134	0.00163	CcSEcCtD
Hydroflumethiazide—Constipation—Vigabatrin—epilepsy syndrome	0.000134	0.00163	CcSEcCtD
Hydroflumethiazide—Urticaria—Midazolam—epilepsy syndrome	0.000134	0.00163	CcSEcCtD
Hydroflumethiazide—Anorexia—Phenytoin—epilepsy syndrome	0.000133	0.00162	CcSEcCtD
Hydroflumethiazide—Asthenia—Acetazolamide—epilepsy syndrome	0.000133	0.00162	CcSEcCtD
Hydroflumethiazide—Orthostatic hypotension—Topiramate—epilepsy syndrome	0.000133	0.00162	CcSEcCtD
Hydroflumethiazide—Anorexia—Oxcarbazepine—epilepsy syndrome	0.000133	0.00161	CcSEcCtD
Hydroflumethiazide—Vomiting—Clobazam—epilepsy syndrome	0.000133	0.00161	CcSEcCtD
Hydroflumethiazide—Constipation—Diazepam—epilepsy syndrome	0.000132	0.0016	CcSEcCtD
Hydroflumethiazide—Rash—Clobazam—epilepsy syndrome	0.000131	0.0016	CcSEcCtD
Hydroflumethiazide—Dermatitis—Clobazam—epilepsy syndrome	0.000131	0.0016	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Carbamazepine—epilepsy syndrome	0.000131	0.00159	CcSEcCtD
Hydroflumethiazide—Headache—Clobazam—epilepsy syndrome	0.000131	0.00159	CcSEcCtD
Hydroflumethiazide—Jaundice—Gabapentin—epilepsy syndrome	0.00013	0.00158	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Felbamate—epilepsy syndrome	0.00013	0.00158	CcSEcCtD
Hydroflumethiazide—Urticaria—Fosphenytoin—epilepsy syndrome	0.000128	0.00155	CcSEcCtD
Hydroflumethiazide—Constipation—Felbamate—epilepsy syndrome	0.000128	0.00155	CcSEcCtD
Hydroflumethiazide—Nausea—Lacosamide—epilepsy syndrome	0.000128	0.00155	CcSEcCtD
Hydroflumethiazide—Anorexia—Carbamazepine—epilepsy syndrome	0.000127	0.00155	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Zonisamide—epilepsy syndrome	0.000127	0.00155	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Acetazolamide—epilepsy syndrome	0.000127	0.00154	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Lamotrigine—epilepsy syndrome	0.000127	0.00154	CcSEcCtD
Hydroflumethiazide—Constipation—Zonisamide—epilepsy syndrome	0.000125	0.00152	CcSEcCtD
Hydroflumethiazide—Urticaria—Vigabatrin—epilepsy syndrome	0.000125	0.00151	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Midazolam—epilepsy syndrome	0.000124	0.00151	CcSEcCtD
Hydroflumethiazide—Nausea—Clobazam—epilepsy syndrome	0.000124	0.0015	CcSEcCtD
Hydroflumethiazide—Asthenia—Propofol—epilepsy syndrome	0.000124	0.0015	CcSEcCtD
Hydroflumethiazide—Pancreatitis—Topiramate—epilepsy syndrome	0.000123	0.0015	CcSEcCtD
Hydroflumethiazide—Anorexia—Lamotrigine—epilepsy syndrome	0.000123	0.0015	CcSEcCtD
Hydroflumethiazide—Dizziness—Acetazolamide—epilepsy syndrome	0.000123	0.00149	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Levetiracetam—epilepsy syndrome	0.000123	0.00149	CcSEcCtD
Hydroflumethiazide—Urticaria—Diazepam—epilepsy syndrome	0.000123	0.00149	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Clonazepam—epilepsy syndrome	0.000123	0.00149	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Phenytoin—epilepsy syndrome	0.000122	0.00148	CcSEcCtD
Hydroflumethiazide—Asthenia—Midazolam—epilepsy syndrome	0.000121	0.00147	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Oxcarbazepine—epilepsy syndrome	0.000121	0.00147	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Valproic Acid—epilepsy syndrome	0.000121	0.00147	CcSEcCtD
Hydroflumethiazide—Constipation—Clonazepam—epilepsy syndrome	0.000121	0.00147	CcSEcCtD
Hydroflumethiazide—Constipation—Phenytoin—epilepsy syndrome	0.00012	0.00146	CcSEcCtD
Hydroflumethiazide—Asthenia—Levetiracetam—epilepsy syndrome	0.00012	0.00145	CcSEcCtD
Hydroflumethiazide—Constipation—Oxcarbazepine—epilepsy syndrome	0.000119	0.00145	CcSEcCtD
Hydroflumethiazide—Urticaria—Felbamate—epilepsy syndrome	0.000119	0.00144	CcSEcCtD
Hydroflumethiazide—Vomiting—Acetazolamide—epilepsy syndrome	0.000118	0.00144	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Propofol—epilepsy syndrome	0.000118	0.00143	CcSEcCtD
Hydroflumethiazide—CA2—brain—epilepsy syndrome	0.000117	0.00389	CbGeAlD
Hydroflumethiazide—Headache—Acetazolamide—epilepsy syndrome	0.000116	0.00141	CcSEcCtD
Hydroflumethiazide—Urticaria—Zonisamide—epilepsy syndrome	0.000116	0.00141	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Carbamazepine—epilepsy syndrome	0.000116	0.00141	CcSEcCtD
Hydroflumethiazide—Agitation—Valproic Acid—epilepsy syndrome	0.000116	0.0014	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Vigabatrin—epilepsy syndrome	0.000116	0.0014	CcSEcCtD
Hydroflumethiazide—Asthenia—Fosphenytoin—epilepsy syndrome	0.000115	0.0014	CcSEcCtD
Hydroflumethiazide—Photosensitivity reaction—Topiramate—epilepsy syndrome	0.000115	0.0014	CcSEcCtD
Hydroflumethiazide—Constipation—Carbamazepine—epilepsy syndrome	0.000114	0.00139	CcSEcCtD
Hydroflumethiazide—Dizziness—Propofol—epilepsy syndrome	0.000114	0.00139	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Levetiracetam—epilepsy syndrome	0.000114	0.00139	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Diazepam—epilepsy syndrome	0.000114	0.00138	CcSEcCtD
Hydroflumethiazide—Hyperglycaemia—Topiramate—epilepsy syndrome	0.000114	0.00138	CcSEcCtD
Hydroflumethiazide—Vertigo—Valproic Acid—epilepsy syndrome	0.000113	0.00137	CcSEcCtD
Hydroflumethiazide—Leukopenia—Valproic Acid—epilepsy syndrome	0.000113	0.00137	CcSEcCtD
Hydroflumethiazide—Asthenia—Vigabatrin—epilepsy syndrome	0.000113	0.00137	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Lamotrigine—epilepsy syndrome	0.000112	0.00136	CcSEcCtD
Hydroflumethiazide—Urticaria—Clonazepam—epilepsy syndrome	0.000112	0.00136	CcSEcCtD
Hydroflumethiazide—Dizziness—Midazolam—epilepsy syndrome	0.000112	0.00136	CcSEcCtD
Hydroflumethiazide—Urticaria—Phenytoin—epilepsy syndrome	0.000111	0.00135	CcSEcCtD
Hydroflumethiazide—Asthenia—Diazepam—epilepsy syndrome	0.000111	0.00135	CcSEcCtD
Hydroflumethiazide—Urticaria—Oxcarbazepine—epilepsy syndrome	0.000111	0.00134	CcSEcCtD
Hydroflumethiazide—Constipation—Lamotrigine—epilepsy syndrome	0.00011	0.00134	CcSEcCtD
Hydroflumethiazide—Nausea—Acetazolamide—epilepsy syndrome	0.00011	0.00134	CcSEcCtD
Hydroflumethiazide—Dizziness—Levetiracetam—epilepsy syndrome	0.00011	0.00134	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Fosphenytoin—epilepsy syndrome	0.00011	0.00134	CcSEcCtD
Hydroflumethiazide—Vomiting—Propofol—epilepsy syndrome	0.00011	0.00133	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Pregabalin—epilepsy syndrome	0.000109	0.00133	CcSEcCtD
Hydroflumethiazide—Rash—Propofol—epilepsy syndrome	0.000109	0.00132	CcSEcCtD
Hydroflumethiazide—Dermatitis—Propofol—epilepsy syndrome	0.000109	0.00132	CcSEcCtD
Hydroflumethiazide—Headache—Propofol—epilepsy syndrome	0.000108	0.00131	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Zonisamide—epilepsy syndrome	0.000108	0.00131	CcSEcCtD
Hydroflumethiazide—Vomiting—Midazolam—epilepsy syndrome	0.000107	0.0013	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Vigabatrin—epilepsy syndrome	0.000107	0.0013	CcSEcCtD
Hydroflumethiazide—Asthenia—Felbamate—epilepsy syndrome	0.000107	0.0013	CcSEcCtD
Hydroflumethiazide—Rash—Midazolam—epilepsy syndrome	0.000106	0.00129	CcSEcCtD
Hydroflumethiazide—Dizziness—Fosphenytoin—epilepsy syndrome	0.000106	0.00129	CcSEcCtD
Hydroflumethiazide—Dermatitis—Midazolam—epilepsy syndrome	0.000106	0.00129	CcSEcCtD
Hydroflumethiazide—Urticaria—Carbamazepine—epilepsy syndrome	0.000106	0.00129	CcSEcCtD
Hydroflumethiazide—Vomiting—Levetiracetam—epilepsy syndrome	0.000106	0.00129	CcSEcCtD
Hydroflumethiazide—Headache—Midazolam—epilepsy syndrome	0.000106	0.00129	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Diazepam—epilepsy syndrome	0.000106	0.00128	CcSEcCtD
Hydroflumethiazide—Rash—Levetiracetam—epilepsy syndrome	0.000105	0.00128	CcSEcCtD
Hydroflumethiazide—Dermatitis—Levetiracetam—epilepsy syndrome	0.000105	0.00128	CcSEcCtD
Hydroflumethiazide—Asthenia—Zonisamide—epilepsy syndrome	0.000105	0.00128	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Topiramate—epilepsy syndrome	0.000105	0.00127	CcSEcCtD
Hydroflumethiazide—Agitation—Pregabalin—epilepsy syndrome	0.000105	0.00127	CcSEcCtD
Hydroflumethiazide—Headache—Levetiracetam—epilepsy syndrome	0.000104	0.00127	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Clonazepam—epilepsy syndrome	0.000104	0.00126	CcSEcCtD
Hydroflumethiazide—Dizziness—Vigabatrin—epilepsy syndrome	0.000104	0.00126	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Phenytoin—epilepsy syndrome	0.000103	0.00125	CcSEcCtD
Hydroflumethiazide—Urticaria—Lamotrigine—epilepsy syndrome	0.000103	0.00125	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.000103	0.00125	CcSEcCtD
Hydroflumethiazide—Nausea—Propofol—epilepsy syndrome	0.000103	0.00125	CcSEcCtD
Hydroflumethiazide—Vomiting—Fosphenytoin—epilepsy syndrome	0.000102	0.00124	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Felbamate—epilepsy syndrome	0.000102	0.00124	CcSEcCtD
Hydroflumethiazide—Vertigo—Pregabalin—epilepsy syndrome	0.000102	0.00124	CcSEcCtD
Hydroflumethiazide—Dizziness—Diazepam—epilepsy syndrome	0.000102	0.00124	CcSEcCtD
Hydroflumethiazide—Leukopenia—Pregabalin—epilepsy syndrome	0.000102	0.00124	CcSEcCtD
Hydroflumethiazide—Rash—Fosphenytoin—epilepsy syndrome	0.000101	0.00123	CcSEcCtD
Hydroflumethiazide—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000101	0.00123	CcSEcCtD
Hydroflumethiazide—Asthenia—Clonazepam—epilepsy syndrome	0.000101	0.00123	CcSEcCtD
Hydroflumethiazide—Headache—Fosphenytoin—epilepsy syndrome	0.000101	0.00122	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Valproic Acid—epilepsy syndrome	0.000101	0.00122	CcSEcCtD
Hydroflumethiazide—Asthenia—Phenytoin—epilepsy syndrome	0.0001	0.00122	CcSEcCtD
Hydroflumethiazide—Nausea—Midazolam—epilepsy syndrome	0.0001	0.00122	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Gabapentin—epilepsy syndrome	0.0001	0.00122	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Zonisamide—epilepsy syndrome	0.0001	0.00122	CcSEcCtD
Hydroflumethiazide—Asthenia—Oxcarbazepine—epilepsy syndrome	0.0001	0.00121	CcSEcCtD
Hydroflumethiazide—Vomiting—Vigabatrin—epilepsy syndrome	9.97e-05	0.00121	CcSEcCtD
Hydroflumethiazide—Nausea—Levetiracetam—epilepsy syndrome	9.9e-05	0.0012	CcSEcCtD
Hydroflumethiazide—Rash—Vigabatrin—epilepsy syndrome	9.89e-05	0.0012	CcSEcCtD
Hydroflumethiazide—Dizziness—Felbamate—epilepsy syndrome	9.88e-05	0.0012	CcSEcCtD
Hydroflumethiazide—Dermatitis—Vigabatrin—epilepsy syndrome	9.88e-05	0.0012	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Carbamazepine—epilepsy syndrome	9.85e-05	0.0012	CcSEcCtD
Hydroflumethiazide—Headache—Vigabatrin—epilepsy syndrome	9.83e-05	0.00119	CcSEcCtD
Hydroflumethiazide—Vomiting—Diazepam—epilepsy syndrome	9.82e-05	0.00119	CcSEcCtD
Hydroflumethiazide—Anorexia—Valproic Acid—epilepsy syndrome	9.79e-05	0.00119	CcSEcCtD
Hydroflumethiazide—Rash—Diazepam—epilepsy syndrome	9.74e-05	0.00118	CcSEcCtD
Hydroflumethiazide—Dermatitis—Diazepam—epilepsy syndrome	9.73e-05	0.00118	CcSEcCtD
Hydroflumethiazide—Dizziness—Zonisamide—epilepsy syndrome	9.67e-05	0.00118	CcSEcCtD
Hydroflumethiazide—Headache—Diazepam—epilepsy syndrome	9.67e-05	0.00118	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Clonazepam—epilepsy syndrome	9.65e-05	0.00117	CcSEcCtD
Hydroflumethiazide—Asthenia—Carbamazepine—epilepsy syndrome	9.59e-05	0.00117	CcSEcCtD
Hydroflumethiazide—Agitation—Gabapentin—epilepsy syndrome	9.58e-05	0.00116	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Phenytoin—epilepsy syndrome	9.58e-05	0.00116	CcSEcCtD
Hydroflumethiazide—Nausea—Fosphenytoin—epilepsy syndrome	9.56e-05	0.00116	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Oxcarbazepine—epilepsy syndrome	9.53e-05	0.00116	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Lamotrigine—epilepsy syndrome	9.52e-05	0.00116	CcSEcCtD
Hydroflumethiazide—Vomiting—Felbamate—epilepsy syndrome	9.5e-05	0.00115	CcSEcCtD
Hydroflumethiazide—Rash—Felbamate—epilepsy syndrome	9.42e-05	0.00115	CcSEcCtD
Hydroflumethiazide—Dermatitis—Felbamate—epilepsy syndrome	9.41e-05	0.00114	CcSEcCtD
Hydroflumethiazide—Vertigo—Gabapentin—epilepsy syndrome	9.37e-05	0.00114	CcSEcCtD
Hydroflumethiazide—Headache—Felbamate—epilepsy syndrome	9.36e-05	0.00114	CcSEcCtD
Hydroflumethiazide—Leukopenia—Gabapentin—epilepsy syndrome	9.33e-05	0.00113	CcSEcCtD
Hydroflumethiazide—Dizziness—Clonazepam—epilepsy syndrome	9.32e-05	0.00113	CcSEcCtD
Hydroflumethiazide—Nausea—Vigabatrin—epilepsy syndrome	9.32e-05	0.00113	CcSEcCtD
Hydroflumethiazide—Vomiting—Zonisamide—epilepsy syndrome	9.3e-05	0.00113	CcSEcCtD
Hydroflumethiazide—Asthenia—Lamotrigine—epilepsy syndrome	9.27e-05	0.00113	CcSEcCtD
Hydroflumethiazide—Dizziness—Phenytoin—epilepsy syndrome	9.26e-05	0.00113	CcSEcCtD
Hydroflumethiazide—Rash—Zonisamide—epilepsy syndrome	9.22e-05	0.00112	CcSEcCtD
Hydroflumethiazide—Dermatitis—Zonisamide—epilepsy syndrome	9.22e-05	0.00112	CcSEcCtD
Hydroflumethiazide—Dizziness—Oxcarbazepine—epilepsy syndrome	9.21e-05	0.00112	CcSEcCtD
Hydroflumethiazide—Nausea—Diazepam—epilepsy syndrome	9.17e-05	0.00111	CcSEcCtD
Hydroflumethiazide—Headache—Zonisamide—epilepsy syndrome	9.16e-05	0.00111	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Carbamazepine—epilepsy syndrome	9.15e-05	0.00111	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Pregabalin—epilepsy syndrome	9.09e-05	0.0011	CcSEcCtD
Hydroflumethiazide—Vomiting—Clonazepam—epilepsy syndrome	8.96e-05	0.00109	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Valproic Acid—epilepsy syndrome	8.92e-05	0.00108	CcSEcCtD
Hydroflumethiazide—Vomiting—Phenytoin—epilepsy syndrome	8.9e-05	0.00108	CcSEcCtD
Hydroflumethiazide—Rash—Clonazepam—epilepsy syndrome	8.89e-05	0.00108	CcSEcCtD
Hydroflumethiazide—Dermatitis—Clonazepam—epilepsy syndrome	8.88e-05	0.00108	CcSEcCtD
Hydroflumethiazide—Nausea—Felbamate—epilepsy syndrome	8.88e-05	0.00108	CcSEcCtD
Hydroflumethiazide—Vomiting—Oxcarbazepine—epilepsy syndrome	8.86e-05	0.00108	CcSEcCtD
Hydroflumethiazide—Anorexia—Pregabalin—epilepsy syndrome	8.85e-05	0.00108	CcSEcCtD
Hydroflumethiazide—Dizziness—Carbamazepine—epilepsy syndrome	8.84e-05	0.00107	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Lamotrigine—epilepsy syndrome	8.84e-05	0.00107	CcSEcCtD
Hydroflumethiazide—Headache—Clonazepam—epilepsy syndrome	8.83e-05	0.00107	CcSEcCtD
Hydroflumethiazide—Rash—Phenytoin—epilepsy syndrome	8.83e-05	0.00107	CcSEcCtD
Hydroflumethiazide—Dermatitis—Phenytoin—epilepsy syndrome	8.82e-05	0.00107	CcSEcCtD
Hydroflumethiazide—Rash—Oxcarbazepine—epilepsy syndrome	8.78e-05	0.00107	CcSEcCtD
Hydroflumethiazide—Constipation—Valproic Acid—epilepsy syndrome	8.78e-05	0.00107	CcSEcCtD
Hydroflumethiazide—Dermatitis—Oxcarbazepine—epilepsy syndrome	8.78e-05	0.00107	CcSEcCtD
Hydroflumethiazide—Headache—Phenytoin—epilepsy syndrome	8.77e-05	0.00107	CcSEcCtD
Hydroflumethiazide—Headache—Oxcarbazepine—epilepsy syndrome	8.73e-05	0.00106	CcSEcCtD
Hydroflumethiazide—Nausea—Zonisamide—epilepsy syndrome	8.69e-05	0.00106	CcSEcCtD
Hydroflumethiazide—Dizziness—Lamotrigine—epilepsy syndrome	8.54e-05	0.00104	CcSEcCtD
Hydroflumethiazide—Vomiting—Carbamazepine—epilepsy syndrome	8.5e-05	0.00103	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Topiramate—epilepsy syndrome	8.44e-05	0.00102	CcSEcCtD
Hydroflumethiazide—Rash—Carbamazepine—epilepsy syndrome	8.43e-05	0.00102	CcSEcCtD
Hydroflumethiazide—Dermatitis—Carbamazepine—epilepsy syndrome	8.42e-05	0.00102	CcSEcCtD
Hydroflumethiazide—Nausea—Clonazepam—epilepsy syndrome	8.37e-05	0.00102	CcSEcCtD
Hydroflumethiazide—Headache—Carbamazepine—epilepsy syndrome	8.37e-05	0.00102	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Gabapentin—epilepsy syndrome	8.33e-05	0.00101	CcSEcCtD
Hydroflumethiazide—Nausea—Phenytoin—epilepsy syndrome	8.32e-05	0.00101	CcSEcCtD
Hydroflumethiazide—Nausea—Oxcarbazepine—epilepsy syndrome	8.27e-05	0.00101	CcSEcCtD
Hydroflumethiazide—Vomiting—Lamotrigine—epilepsy syndrome	8.21e-05	0.000998	CcSEcCtD
Hydroflumethiazide—Urticaria—Valproic Acid—epilepsy syndrome	8.16e-05	0.000991	CcSEcCtD
Hydroflumethiazide—Rash—Lamotrigine—epilepsy syndrome	8.15e-05	0.00099	CcSEcCtD
Hydroflumethiazide—Dermatitis—Lamotrigine—epilepsy syndrome	8.14e-05	0.000989	CcSEcCtD
Hydroflumethiazide—Anorexia—Gabapentin—epilepsy syndrome	8.11e-05	0.000986	CcSEcCtD
Hydroflumethiazide—Headache—Lamotrigine—epilepsy syndrome	8.09e-05	0.000984	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Pregabalin—epilepsy syndrome	8.07e-05	0.00098	CcSEcCtD
Hydroflumethiazide—Agitation—Topiramate—epilepsy syndrome	8.06e-05	0.00098	CcSEcCtD
Hydroflumethiazide—Nausea—Carbamazepine—epilepsy syndrome	7.94e-05	0.000965	CcSEcCtD
Hydroflumethiazide—Constipation—Pregabalin—epilepsy syndrome	7.94e-05	0.000964	CcSEcCtD
Hydroflumethiazide—Vertigo—Topiramate—epilepsy syndrome	7.88e-05	0.000958	CcSEcCtD
Hydroflumethiazide—Leukopenia—Topiramate—epilepsy syndrome	7.85e-05	0.000954	CcSEcCtD
Hydroflumethiazide—Nausea—Lamotrigine—epilepsy syndrome	7.67e-05	0.000933	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Valproic Acid—epilepsy syndrome	7.56e-05	0.000919	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Gabapentin—epilepsy syndrome	7.4e-05	0.000899	CcSEcCtD
Hydroflumethiazide—Urticaria—Pregabalin—epilepsy syndrome	7.37e-05	0.000896	CcSEcCtD
Hydroflumethiazide—Asthenia—Valproic Acid—epilepsy syndrome	7.37e-05	0.000895	CcSEcCtD
Hydroflumethiazide—Constipation—Gabapentin—epilepsy syndrome	7.28e-05	0.000884	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Valproic Acid—epilepsy syndrome	7.02e-05	0.000854	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Topiramate—epilepsy syndrome	7.01e-05	0.000852	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Pregabalin—epilepsy syndrome	6.84e-05	0.000831	CcSEcCtD
Hydroflumethiazide—Anorexia—Topiramate—epilepsy syndrome	6.83e-05	0.000829	CcSEcCtD
Hydroflumethiazide—Dizziness—Valproic Acid—epilepsy syndrome	6.79e-05	0.000825	CcSEcCtD
Hydroflumethiazide—Urticaria—Gabapentin—epilepsy syndrome	6.76e-05	0.000822	CcSEcCtD
Hydroflumethiazide—Asthenia—Pregabalin—epilepsy syndrome	6.66e-05	0.000809	CcSEcCtD
Hydroflumethiazide—Vomiting—Valproic Acid—epilepsy syndrome	6.53e-05	0.000793	CcSEcCtD
Hydroflumethiazide—Rash—Valproic Acid—epilepsy syndrome	6.47e-05	0.000787	CcSEcCtD
Hydroflumethiazide—Dermatitis—Valproic Acid—epilepsy syndrome	6.47e-05	0.000786	CcSEcCtD
Hydroflumethiazide—Headache—Valproic Acid—epilepsy syndrome	6.43e-05	0.000782	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Pregabalin—epilepsy syndrome	6.35e-05	0.000772	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Gabapentin—epilepsy syndrome	6.27e-05	0.000762	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Topiramate—epilepsy syndrome	6.22e-05	0.000756	CcSEcCtD
Hydroflumethiazide—Dizziness—Pregabalin—epilepsy syndrome	6.14e-05	0.000746	CcSEcCtD
Hydroflumethiazide—Constipation—Topiramate—epilepsy syndrome	6.12e-05	0.000744	CcSEcCtD
Hydroflumethiazide—Asthenia—Gabapentin—epilepsy syndrome	6.11e-05	0.000742	CcSEcCtD
Hydroflumethiazide—Nausea—Valproic Acid—epilepsy syndrome	6.1e-05	0.000741	CcSEcCtD
Hydroflumethiazide—Vomiting—Pregabalin—epilepsy syndrome	5.9e-05	0.000717	CcSEcCtD
Hydroflumethiazide—Rash—Pregabalin—epilepsy syndrome	5.85e-05	0.000711	CcSEcCtD
Hydroflumethiazide—Dermatitis—Pregabalin—epilepsy syndrome	5.85e-05	0.00071	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Gabapentin—epilepsy syndrome	5.82e-05	0.000708	CcSEcCtD
Hydroflumethiazide—Headache—Pregabalin—epilepsy syndrome	5.81e-05	0.000707	CcSEcCtD
Hydroflumethiazide—Urticaria—Topiramate—epilepsy syndrome	5.69e-05	0.000691	CcSEcCtD
Hydroflumethiazide—Dizziness—Gabapentin—epilepsy syndrome	5.63e-05	0.000684	CcSEcCtD
Hydroflumethiazide—Nausea—Pregabalin—epilepsy syndrome	5.51e-05	0.00067	CcSEcCtD
Hydroflumethiazide—Vomiting—Gabapentin—epilepsy syndrome	5.41e-05	0.000658	CcSEcCtD
Hydroflumethiazide—Rash—Gabapentin—epilepsy syndrome	5.37e-05	0.000652	CcSEcCtD
Hydroflumethiazide—Dermatitis—Gabapentin—epilepsy syndrome	5.36e-05	0.000651	CcSEcCtD
Hydroflumethiazide—Headache—Gabapentin—epilepsy syndrome	5.33e-05	0.000648	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Topiramate—epilepsy syndrome	5.28e-05	0.000641	CcSEcCtD
Hydroflumethiazide—Asthenia—Topiramate—epilepsy syndrome	5.14e-05	0.000624	CcSEcCtD
Hydroflumethiazide—Nausea—Gabapentin—epilepsy syndrome	5.06e-05	0.000614	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Topiramate—epilepsy syndrome	4.9e-05	0.000595	CcSEcCtD
Hydroflumethiazide—Dizziness—Topiramate—epilepsy syndrome	4.74e-05	0.000575	CcSEcCtD
Hydroflumethiazide—Vomiting—Topiramate—epilepsy syndrome	4.55e-05	0.000553	CcSEcCtD
Hydroflumethiazide—Rash—Topiramate—epilepsy syndrome	4.51e-05	0.000549	CcSEcCtD
Hydroflumethiazide—Dermatitis—Topiramate—epilepsy syndrome	4.51e-05	0.000548	CcSEcCtD
Hydroflumethiazide—Headache—Topiramate—epilepsy syndrome	4.49e-05	0.000545	CcSEcCtD
Hydroflumethiazide—Nausea—Topiramate—epilepsy syndrome	4.25e-05	0.000517	CcSEcCtD
Hydroflumethiazide—CA12—Metabolism—TXNRD1—epilepsy syndrome	1.74e-05	0.000219	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—PPP1R3C—epilepsy syndrome	1.74e-05	0.000219	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—GBE1—epilepsy syndrome	1.74e-05	0.000219	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Circadian rythm related genes—JUN—epilepsy syndrome	1.74e-05	0.000219	CbGpPWpGaD
Hydroflumethiazide—CA9—HIF-1-alpha transcription factor network—AKT1—epilepsy syndrome	1.74e-05	0.000219	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—STXBP1—epilepsy syndrome	1.73e-05	0.000218	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—ASAH1—epilepsy syndrome	1.71e-05	0.000215	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—AQP1—epilepsy syndrome	1.69e-05	0.000213	CbGpPWpGaD
Hydroflumethiazide—SLC12A1—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	1.69e-05	0.000213	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—NT5E—epilepsy syndrome	1.69e-05	0.000212	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—ALAD—epilepsy syndrome	1.69e-05	0.000212	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—STXBP1—epilepsy syndrome	1.66e-05	0.000209	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—KCNJ11—epilepsy syndrome	1.65e-05	0.000208	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—CHRM3—epilepsy syndrome	1.65e-05	0.000208	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—KCNJ11—epilepsy syndrome	1.65e-05	0.000208	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—CHRM3—epilepsy syndrome	1.65e-05	0.000208	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—NEU1—epilepsy syndrome	1.65e-05	0.000207	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—ATIC—epilepsy syndrome	1.65e-05	0.000207	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—UPB1—epilepsy syndrome	1.65e-05	0.000207	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—ASAH1—epilepsy syndrome	1.64e-05	0.000206	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—NT5E—epilepsy syndrome	1.62e-05	0.000204	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—ALAD—epilepsy syndrome	1.62e-05	0.000204	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—ALDH7A1—epilepsy syndrome	1.61e-05	0.000203	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—CACNA1A—epilepsy syndrome	1.61e-05	0.000203	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—ATM—epilepsy syndrome	1.6e-05	0.000202	CbGpPWpGaD
Hydroflumethiazide—ATP1A1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	1.6e-05	0.000202	CbGpPWpGaD
Hydroflumethiazide—SLC12A3—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	1.6e-05	0.000202	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—FYN—epilepsy syndrome	1.6e-05	0.000201	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—STXBP1—epilepsy syndrome	1.59e-05	0.0002	CbGpPWpGaD
Hydroflumethiazide—ATP1A1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	1.59e-05	0.0002	CbGpPWpGaD
Hydroflumethiazide—SLC12A3—Transmembrane transport of small molecules—AVP—epilepsy syndrome	1.59e-05	0.0002	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—HSD17B4—epilepsy syndrome	1.59e-05	0.000199	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—ST3GAL3—epilepsy syndrome	1.58e-05	0.000198	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—NT5E—epilepsy syndrome	1.55e-05	0.000195	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—ALAD—epilepsy syndrome	1.55e-05	0.000195	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—CACNA1A—epilepsy syndrome	1.55e-05	0.000194	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—ADSL—epilepsy syndrome	1.55e-05	0.000194	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—ALDH7A1—epilepsy syndrome	1.55e-05	0.000194	CbGpPWpGaD
Hydroflumethiazide—SLC12A3—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	1.54e-05	0.000193	CbGpPWpGaD
Hydroflumethiazide—ATP1A1—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	1.54e-05	0.000193	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—YWHAZ—epilepsy syndrome	1.54e-05	0.000193	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—GBE1—epilepsy syndrome	1.53e-05	0.000193	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—PPP1R3C—epilepsy syndrome	1.53e-05	0.000193	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—CHRM3—epilepsy syndrome	1.53e-05	0.000193	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—KCNJ11—epilepsy syndrome	1.53e-05	0.000193	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—GLUL—epilepsy syndrome	1.52e-05	0.000191	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—ST3GAL3—epilepsy syndrome	1.51e-05	0.00019	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—CACNA1D—epilepsy syndrome	1.49e-05	0.000187	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—ALDH7A1—epilepsy syndrome	1.48e-05	0.000186	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—ADSL—epilepsy syndrome	1.48e-05	0.000186	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—CACNA1A—epilepsy syndrome	1.48e-05	0.000186	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—ABCG2—epilepsy syndrome	1.48e-05	0.000186	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—GLUL—epilepsy syndrome	1.45e-05	0.000183	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—ST3GAL3—epilepsy syndrome	1.45e-05	0.000182	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—CYP2C19—epilepsy syndrome	1.44e-05	0.000182	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—ASAH1—epilepsy syndrome	1.44e-05	0.000181	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—CYP11A1—epilepsy syndrome	1.43e-05	0.00018	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—FOS—epilepsy syndrome	1.43e-05	0.00018	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—CACNA1D—epilepsy syndrome	1.43e-05	0.000179	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—ADSL—epilepsy syndrome	1.42e-05	0.000179	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—STXBP1—epilepsy syndrome	1.4e-05	0.000176	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—GLUL—epilepsy syndrome	1.39e-05	0.000175	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—TXNRD1—epilepsy syndrome	1.39e-05	0.000175	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—CACNA1D—epilepsy syndrome	1.37e-05	0.000172	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—NT5E—epilepsy syndrome	1.37e-05	0.000172	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—ALAD—epilepsy syndrome	1.37e-05	0.000172	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—PLAU—epilepsy syndrome	1.36e-05	0.000172	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—AQP1—epilepsy syndrome	1.35e-05	0.00017	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—ABCG2—epilepsy syndrome	1.35e-05	0.00017	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—ABCG2—epilepsy syndrome	1.35e-05	0.00017	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—TXNRD1—epilepsy syndrome	1.33e-05	0.000168	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—CYP2C19—epilepsy syndrome	1.31e-05	0.000165	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—CYP2C19—epilepsy syndrome	1.31e-05	0.000165	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—CYP11A1—epilepsy syndrome	1.31e-05	0.000164	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—CYP11A1—epilepsy syndrome	1.31e-05	0.000164	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—ALDH7A1—epilepsy syndrome	1.3e-05	0.000164	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—CACNA1A—epilepsy syndrome	1.3e-05	0.000164	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—AQP1—epilepsy syndrome	1.29e-05	0.000163	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—CYP2D6—epilepsy syndrome	1.29e-05	0.000163	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—TXNRD1—epilepsy syndrome	1.28e-05	0.000161	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—ST3GAL3—epilepsy syndrome	1.27e-05	0.00016	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—PRKCB—epilepsy syndrome	1.27e-05	0.00016	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—NOS2—epilepsy syndrome	1.25e-05	0.000158	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—ADSL—epilepsy syndrome	1.25e-05	0.000157	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—ABCG2—epilepsy syndrome	1.25e-05	0.000157	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—AQP1—epilepsy syndrome	1.24e-05	0.000156	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—ADRA2A—epilepsy syndrome	1.23e-05	0.000155	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—BCHE—epilepsy syndrome	1.23e-05	0.000154	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—GLUL—epilepsy syndrome	1.22e-05	0.000154	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—CHRM3—epilepsy syndrome	1.22e-05	0.000154	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—KCNJ11—epilepsy syndrome	1.22e-05	0.000154	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—CYP2C19—epilepsy syndrome	1.22e-05	0.000153	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—CYP11A1—epilepsy syndrome	1.21e-05	0.000152	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—CACNA1D—epilepsy syndrome	1.2e-05	0.000151	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—CYP2D6—epilepsy syndrome	1.18e-05	0.000148	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—CYP2D6—epilepsy syndrome	1.18e-05	0.000148	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—RELA—epilepsy syndrome	1.17e-05	0.000148	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—SLC2A1—epilepsy syndrome	1.17e-05	0.000147	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—CHRM3—epilepsy syndrome	1.17e-05	0.000147	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—KCNJ11—epilepsy syndrome	1.17e-05	0.000147	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—PLCB1—epilepsy syndrome	1.16e-05	0.000146	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—TH—epilepsy syndrome	1.15e-05	0.000145	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—MTOR—epilepsy syndrome	1.15e-05	0.000145	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—TXNRD1—epilepsy syndrome	1.12e-05	0.000141	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—KCNJ11—epilepsy syndrome	1.12e-05	0.000141	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—CHRM3—epilepsy syndrome	1.12e-05	0.000141	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—ADRA2A—epilepsy syndrome	1.12e-05	0.000141	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—ADRA2A—epilepsy syndrome	1.12e-05	0.000141	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—BCHE—epilepsy syndrome	1.12e-05	0.00014	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—BCHE—epilepsy syndrome	1.12e-05	0.00014	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—AQP1—epilepsy syndrome	1.09e-05	0.000137	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—CYP2D6—epilepsy syndrome	1.09e-05	0.000137	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—SLC2A1—epilepsy syndrome	1.07e-05	0.000134	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—SLC2A1—epilepsy syndrome	1.07e-05	0.000134	CbGpPWpGaD
Hydroflumethiazide—SLC12A1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.06e-05	0.000133	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—PLCB1—epilepsy syndrome	1.05e-05	0.000133	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—PLCB1—epilepsy syndrome	1.05e-05	0.000133	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—ALB—epilepsy syndrome	1.05e-05	0.000133	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—TH—epilepsy syndrome	1.05e-05	0.000132	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—TH—epilepsy syndrome	1.05e-05	0.000132	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—ADRA2A—epilepsy syndrome	1.04e-05	0.000131	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—BCHE—epilepsy syndrome	1.03e-05	0.00013	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—JUN—epilepsy syndrome	1.03e-05	0.000129	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—ABCG2—epilepsy syndrome	9.96e-06	0.000125	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—KCNJ11—epilepsy syndrome	9.87e-06	0.000124	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—CHRM3—epilepsy syndrome	9.87e-06	0.000124	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—SLC2A1—epilepsy syndrome	9.87e-06	0.000124	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—PLCB1—epilepsy syndrome	9.76e-06	0.000123	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—TH—epilepsy syndrome	9.73e-06	0.000122	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—CYP2C19—epilepsy syndrome	9.7e-06	0.000122	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—CYP11A1—epilepsy syndrome	9.64e-06	0.000121	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—HMOX1—epilepsy syndrome	9.63e-06	0.000121	CbGpPWpGaD
Hydroflumethiazide—ATP1A1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	9.62e-06	0.000121	CbGpPWpGaD
Hydroflumethiazide—SLC12A3—Transmembrane transport of small molecules—ALB—epilepsy syndrome	9.62e-06	0.000121	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—ABCG2—epilepsy syndrome	9.55e-06	0.00012	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—CAT—epilepsy syndrome	9.5e-06	0.00012	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—CYP2C19—epilepsy syndrome	9.3e-06	0.000117	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—CYP11A1—epilepsy syndrome	9.25e-06	0.000116	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—ABCB1—epilepsy syndrome	9.25e-06	0.000116	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—ABCG2—epilepsy syndrome	9.15e-06	0.000115	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—VEGFA—epilepsy syndrome	8.99e-06	0.000113	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—CYP2C19—epilepsy syndrome	8.92e-06	0.000112	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—CYP11A1—epilepsy syndrome	8.86e-06	0.000111	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—HMOX1—epilepsy syndrome	8.76e-06	0.00011	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—HMOX1—epilepsy syndrome	8.76e-06	0.00011	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—CYP2D6—epilepsy syndrome	8.7e-06	0.000109	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—CAT—epilepsy syndrome	8.65e-06	0.000109	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—CAT—epilepsy syndrome	8.65e-06	0.000109	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—GPX1—epilepsy syndrome	8.6e-06	0.000108	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—ABCB1—epilepsy syndrome	8.41e-06	0.000106	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—ABCB1—epilepsy syndrome	8.41e-06	0.000106	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—CYP2D6—epilepsy syndrome	8.34e-06	0.000105	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—ADRA2A—epilepsy syndrome	8.29e-06	0.000104	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—BCHE—epilepsy syndrome	8.25e-06	0.000104	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—HMOX1—epilepsy syndrome	8.12e-06	0.000102	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—ABCG2—epilepsy syndrome	8.05e-06	0.000101	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—CAT—epilepsy syndrome	8.01e-06	0.000101	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—CYP2D6—epilepsy syndrome	8e-06	0.000101	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—ADRA2A—epilepsy syndrome	7.94e-06	9.99e-05	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—BCHE—epilepsy syndrome	7.91e-06	9.95e-05	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—SLC2A1—epilepsy syndrome	7.87e-06	9.9e-05	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—CYP2C19—epilepsy syndrome	7.84e-06	9.86e-05	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—GPX1—epilepsy syndrome	7.82e-06	9.83e-05	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—GPX1—epilepsy syndrome	7.82e-06	9.83e-05	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—CYP11A1—epilepsy syndrome	7.79e-06	9.8e-05	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—ABCB1—epilepsy syndrome	7.79e-06	9.8e-05	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—PLCB1—epilepsy syndrome	7.79e-06	9.79e-05	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—TH—epilepsy syndrome	7.76e-06	9.76e-05	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—ADRA2A—epilepsy syndrome	7.62e-06	9.58e-05	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—BCHE—epilepsy syndrome	7.58e-06	9.54e-05	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—SLC2A1—epilepsy syndrome	7.55e-06	9.49e-05	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—AGT—epilepsy syndrome	7.54e-06	9.48e-05	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—PLCB1—epilepsy syndrome	7.46e-06	9.39e-05	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—SRC—epilepsy syndrome	7.45e-06	9.38e-05	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—TH—epilepsy syndrome	7.44e-06	9.35e-05	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—APOE—epilepsy syndrome	7.39e-06	9.29e-05	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—VEGFA—epilepsy syndrome	7.26e-06	9.13e-05	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—GPX1—epilepsy syndrome	7.24e-06	9.11e-05	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—SLC2A1—epilepsy syndrome	7.24e-06	9.1e-05	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—PLCB1—epilepsy syndrome	7.16e-06	9e-05	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—TH—epilepsy syndrome	7.13e-06	8.97e-05	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—CYP2D6—epilepsy syndrome	7.03e-06	8.84e-05	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—AGT—epilepsy syndrome	6.86e-06	8.62e-05	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—AGT—epilepsy syndrome	6.86e-06	8.62e-05	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—APOE—epilepsy syndrome	6.72e-06	8.45e-05	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—APOE—epilepsy syndrome	6.72e-06	8.45e-05	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—ADRA2A—epilepsy syndrome	6.7e-06	8.42e-05	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—BCHE—epilepsy syndrome	6.67e-06	8.38e-05	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—HMOX1—epilepsy syndrome	6.47e-06	8.14e-05	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—CAT—epilepsy syndrome	6.39e-06	8.03e-05	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—SLC2A1—epilepsy syndrome	6.36e-06	8e-05	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—AGT—epilepsy syndrome	6.35e-06	7.99e-05	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—POMC—epilepsy syndrome	6.34e-06	7.98e-05	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—PLCB1—epilepsy syndrome	6.29e-06	7.91e-05	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—TH—epilepsy syndrome	6.27e-06	7.88e-05	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—APOE—epilepsy syndrome	6.22e-06	7.83e-05	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—ABCB1—epilepsy syndrome	6.21e-06	7.82e-05	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—HMOX1—epilepsy syndrome	6.21e-06	7.81e-05	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—CAT—epilepsy syndrome	6.12e-06	7.7e-05	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—ABCB1—epilepsy syndrome	5.96e-06	7.49e-05	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—HMOX1—epilepsy syndrome	5.95e-06	7.48e-05	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—CAT—epilepsy syndrome	5.87e-06	7.38e-05	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—ALB—epilepsy syndrome	5.78e-06	7.27e-05	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—GPX1—epilepsy syndrome	5.78e-06	7.27e-05	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—POMC—epilepsy syndrome	5.77e-06	7.26e-05	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—POMC—epilepsy syndrome	5.77e-06	7.26e-05	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—ABCB1—epilepsy syndrome	5.71e-06	7.18e-05	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—GPX1—epilepsy syndrome	5.54e-06	6.97e-05	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—POMC—epilepsy syndrome	5.35e-06	6.72e-05	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—GPX1—epilepsy syndrome	5.31e-06	6.68e-05	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—ALB—epilepsy syndrome	5.26e-06	6.62e-05	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—ALB—epilepsy syndrome	5.26e-06	6.62e-05	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—HMOX1—epilepsy syndrome	5.23e-06	6.58e-05	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—CAT—epilepsy syndrome	5.16e-06	6.49e-05	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—AGT—epilepsy syndrome	5.07e-06	6.37e-05	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—PTGS2—epilepsy syndrome	5.06e-06	6.36e-05	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—ABCB1—epilepsy syndrome	5.02e-06	6.32e-05	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—APOE—epilepsy syndrome	4.96e-06	6.24e-05	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—ALB—epilepsy syndrome	4.88e-06	6.13e-05	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—AGT—epilepsy syndrome	4.86e-06	6.11e-05	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—APOE—epilepsy syndrome	4.76e-06	5.98e-05	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—GPX1—epilepsy syndrome	4.67e-06	5.87e-05	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—AGT—epilepsy syndrome	4.66e-06	5.86e-05	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—AKT1—epilepsy syndrome	4.63e-06	5.83e-05	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—PTGS2—epilepsy syndrome	4.6e-06	5.79e-05	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—PTGS2—epilepsy syndrome	4.6e-06	5.79e-05	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—APOE—epilepsy syndrome	4.56e-06	5.74e-05	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—PTGS2—epilepsy syndrome	4.27e-06	5.36e-05	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—POMC—epilepsy syndrome	4.26e-06	5.36e-05	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—AGT—epilepsy syndrome	4.09e-06	5.15e-05	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—POMC—epilepsy syndrome	4.09e-06	5.14e-05	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—APOE—epilepsy syndrome	4.01e-06	5.04e-05	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—POMC—epilepsy syndrome	3.92e-06	4.93e-05	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—ALB—epilepsy syndrome	3.89e-06	4.89e-05	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—ALB—epilepsy syndrome	3.73e-06	4.69e-05	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—ALB—epilepsy syndrome	3.57e-06	4.49e-05	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—POMC—epilepsy syndrome	3.45e-06	4.33e-05	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—PTGS2—epilepsy syndrome	3.4e-06	4.28e-05	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—PTGS2—epilepsy syndrome	3.26e-06	4.1e-05	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—ALB—epilepsy syndrome	3.14e-06	3.95e-05	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—PTGS2—epilepsy syndrome	3.13e-06	3.93e-05	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—PTGS2—epilepsy syndrome	2.75e-06	3.46e-05	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—AKT1—epilepsy syndrome	2.54e-06	3.2e-05	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—AKT1—epilepsy syndrome	2.31e-06	2.91e-05	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—AKT1—epilepsy syndrome	2.31e-06	2.91e-05	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—AKT1—epilepsy syndrome	2.14e-06	2.7e-05	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—AKT1—epilepsy syndrome	1.71e-06	2.15e-05	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—AKT1—epilepsy syndrome	1.64e-06	2.06e-05	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—AKT1—epilepsy syndrome	1.57e-06	1.98e-05	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—AKT1—epilepsy syndrome	1.38e-06	1.74e-05	CbGpPWpGaD
